Results 181 to 190 of about 1,565,422 (359)

Improvements in Health‐Related Quality of Life with Treat‐to‐Target Urate‐Lowering Therapy in Gout: A Post‐hoc Analysis of a Randomized Multicenter Trial

open access: yesArthritis Care &Research, Accepted Article.
Background While treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL change.
Austin Barry   +16 more
wiley   +1 more source

Chronic Opioids in Gout: A Matched Cohort Study from the Veteran's Health Administration

open access: yesArthritis Care &Research, Accepted Article.
Objective Though used frequently to treat flare, risk of chronic opioid exposure in gout has not been well defined. In this study, we examined the hypothesis that people with gout are more likely than individuals without gout to be prescribed chronic opioids over time.
Lindsay N. Helget   +7 more
wiley   +1 more source

Correction: Comparison of treatment patterns, efficacy and safety between generic and branded Atorvastatin users in China: a multicenter, retrospective propensity score‑matched cohort study. [PDF]

open access: yesLipids Health Dis
Xing X   +21 more
europepmc   +1 more source

Hip morphology‐based osteoarthritis risk prediction models: development and external validation using individual participant data from the World COACH Consortium

open access: yesArthritis Care &Research, Accepted Article.
Objectives This study aims to develop hip morphology‐based radiographic hip osteoarthritis (RHOA) risk prediction models and investigates the added predictive value of hip morphology measurements and the generalizability to different populations. Methods We combined data from nine prospective cohort studies participating in the World COACH consortium ...
Myrthe A. van den Berg   +26 more
wiley   +1 more source

The Role of Pharmacy Benefit Managers in Access to Biologics for Dermatologic Conditions. [PDF]

open access: yesJ Psoriasis Psoriatic Arthritis
Leeolou MC, Jia JL, Harris J, Liao W.
europepmc   +1 more source

Home - About - Disclaimer - Privacy